Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{169333,
        author = {Chaithanya A and Ashok kumar B S and Disha N S and mohammed khalid},
        title = {Exploring the Therapeutic Role of Budesonide in Respiratory and Gastrointestinal Disorders: A Review},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {6},
        pages = {674-680},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=169333},
        abstract = {Objectives: This review examines the efficacy, safety, and therapeutic role of budesonide in respiratory and gastrointestinal disorders, focusing on asthma and Crohn’s disease.
Evidence Acquisition: A comprehensive analysis of existing literature, including systematic reviews and clinical trials, was conducted.
Results: Budesonide showed high efficacy in asthma and Crohn’s disease management with fewer systemic side effects compared to conventional corticosteroids.
Conclusion: Budesonide is an effective corticosteroid for managing chronic inflammatory diseases, with reduced systemic complications. Future research should focus on long-term safety and optimal dosing strategies.},
        keywords = {Formoterol, budesonide, Asthma, Gastrointestinal disorders},
        month = {November},
        }